Shandong Sito Bio-technology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 932.95 million compared to CNY 882.08 million a year ago. Revenue was CNY 932.95 million compared to CNY 882.08 million a year ago.

Net income was CNY 41.31 million compared to CNY 31.58 million a year ago. Basic earnings per share from continuing operations was CNY 0.3851 compared to CNY 0.2978 a year ago. Diluted earnings per share from continuing operations was CNY 0.3851 compared to CNY 0.2978 a year ago.